# Study in Healthy Subjects to Measure Amount of Drug in Blood After Dosing With Different Saxagliptin / Metformin Produc

> **NCT01441869** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 28 (actual)

## Conditions studied

- Bioequivalence, Log-transformed AUCss and Cmax,ss Values for Saxagliptin and Metformin

## Interventions

- **DRUG:** Onglyza (saxagliptin)
- **DRUG:** Diabex
- **DRUG:** 5-mg saxagliptin/1000 mg metformin
- **DRUG:** Diabex
- **DRUG:** 5-mg saxagliptin/500 mg metformin

## Key facts

- **NCT ID:** NCT01441869
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2012-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01441869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01441869, "Study in Healthy Subjects to Measure Amount of Drug in Blood After Dosing With Different Saxagliptin / Metformin Produc". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01441869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*